Pseudomonas aeruginosa develops Ciprofloxacin resistance from low to high level with distinctive proteome changes

Jianhe Peng1, Jing Cao1, Fui Mee Ng1

  • 1Experimental Therapeutics Centre, Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, Nanos #03-01, Singapore 138669, Singapore.

Journal of Proteomics
|November 7, 2016
PubMed

Insights

Ciprofloxacin resistance in Pseudomonas aeruginosa evolves from low to high levels through distinct molecular mechanisms. Understanding these pathways, including efflux pumps and altered respiration, aids in treating resistant infections.

Area of Science:

  • Microbiology
  • Genetics
  • Biochemistry

Background:

  • Pseudomonas aeruginosa infections are challenging due to increasing drug resistance.
  • The mechanisms underlying Ciprofloxacin resistance development in P. aeruginosa are not fully understood.

Purpose of the Study:

  • To investigate the molecular mechanisms of Ciprofloxacin resistance development in Pseudomonas aeruginosa.
  • To identify the proteomic changes associated with increasing levels of Ciprofloxacin resistance.

Main Methods:

  • Quantitative proteomic analysis of Ciprofloxacin-resistant mutants.
  • Selection of low and high-level resistant mutants using varying Ciprofloxacin concentrations.
  • Intracellular Ciprofloxacin concentration assays.

Main Results:

  • Two distinct low-level Ciprofloxacin resistance mechanisms were identified: anaerobic respiration/antioxidant enzyme overexpression and iron/polyamine uptake/DNA repair.
  • High-level resistance involved the mexCD-oprJ efflux pump and downregulation of quorum sensing.
  • Only mexCD-oprJ overexpressing mutants showed reduced intracellular Ciprofloxacin accumulation.

Conclusions:

  • Ciprofloxacin resistance in P. aeruginosa evolves progressively with distinct proteomic underpinnings at different resistance levels.
  • The identified pathways offer potential targets for overcoming Ciprofloxacin resistance.
  • Findings have implications for the diagnosis and treatment of P. aeruginosa infections.